Premium
Prediction of head and neck squamous cell carcinoma survival based on the expression of 15 lncRNAs
Author(s) -
Zhang Boxin,
Wang Haihui,
Guo Ziyan,
Zhang Xinhai
Publication year - 2019
Publication title -
journal of cellular physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 174
eISSN - 1097-4652
pISSN - 0021-9541
DOI - 10.1002/jcp.28517
Subject(s) - head and neck , head and neck squamous cell carcinoma , basal cell , oncology , carcinoma , cell , medicine , protein expression , head (geology) , expression (computer science) , cancer research , biology , head and neck cancer , cancer , computer science , surgery , genetics , gene , paleontology , programming language
Recent evidence suggests that long noncoding RNAs (lncRNAs) are essential regulators of many cancer‐related processes, including cancer cell proliferation, invasion, and migration. There is thus a reason to believe that the detection of lncRNAs may be useful as a diagnostic and prognostic strategy for cancer detection, however, at present no effective genome‐wide tests are available for clinical use, constraining the use of such a strategy. In this study, we performed a comprehensive assessment of lncRNAs expressed in samples in the head and neck squamous cell carcinoma (HNSCC) cohort available in The Cancer Genome Atlas database. A risk score (RS) model was constructed based on the expression data of these 15 lncRNAs in the validation data set of HNSCC patients and was subsequently validated in validation data set and the entire data set. We were able to stratify patients into high‐ and low‐risk categories, using our lncRNA expression panel to determine an RS, with significant differences in overall survival (OS) between these two groups in our test set (median survival, 1.863 vs. 5.484 years; log‐rank test, p < 0.001). We were able to confirm the predictive value of our 15‐lncRNA signature using both a validation data set and a full data set, finding our signature to be reproducible and effective as a means of predicting HNSCC patient OS. Through the multivariate Cox regression and stratified analyses, we were further able to confirm that the predictive value of this RS was independent of other predictive factors such as clinicopathological parameters. The Gene set enrichment analysis revealed potential functional roles for these 15 lncRNAs in tumor progression. Our findings indicate that an RS established based on a panel of lncRNA expression signatures can effectively predict OS and facilitate patient stratification in HNSCC.